Topic
Stevens-Johnson syndrome and toxic epidermal necrolysis
💡 What You Need to Know
- Life-Threatening Reaction: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe, potentially fatal mucocutaneous reactions.
- Drug-Induced Origin: Most cases are triggered by medications, making careful drug management crucial, especially in seniors with polypharmacy.
- Rapid Progression: Characterized by widespread blistering, epidermal detachment, and severe mucosal involvement.
- Spectrum of Severity: SJS involves less than 10% body surface area (BSA) detachment, SJS/TEN overlap 10-30% BSA, and TEN more than 30% BSA.
- Medical Emergency: Requires immediate hospitalization, often in a burn unit or intensive care unit, due to high mortality rates and extensive organ involvement.
🤒 Associated Symptoms
- Prodromal Phase: Often begins with non-specific flu-like symptoms such as fever, malaise, myalgia, and arthralgia, preceding skin lesions by several days.
- Skin Manifestations: Widespread erythematous macules, targetoid lesions, rapidly progressing to flaccid blisters and extensive epidermal detachment.
- Mucosal Involvement: Painful erosions and crusting affecting at least two mucosal sites, commonly oral, ocular, and genital.
- Ocular Symptoms: Severe conjunctivitis, photophobia, blurred vision, and potential corneal erosions.
- Systemic Signs: Tachycardia, hypotension, and signs of organ dysfunction (e.g., renal impairment, respiratory distress) due to systemic inflammation and fluid loss.
- Severe Pain: Patients experience excruciating pain due to extensive skin and mucosal damage.
🛡 Crucial Precautions
- Medication Reconciliation: Meticulously review all current and recently started medications, especially within the preceding 8 weeks, for potential culprits.
- High-Risk Medications: Be vigilant with drugs commonly implicated, including allopurinol, sulfonamide antibiotics, anti-epileptics (e.g., carbamazepine, lamotrigine, phenytoin), and certain NSAIDs.
- Early Symptom Recognition: Educate patients and caregivers to promptly report any new rash, blistering, or mucosal pain, particularly if accompanied by fever or flu-like symptoms.
- Avoid Re-exposure: Absolutely critical to identify and permanently discontinue the causative drug and all chemically related compounds to prevent recurrence.
- Genetic Screening: Consider pharmacogenetic testing (e.g., HLA-B*1502 for carbamazepine in certain Asian populations, HLA-B*5801 for allopurinol in specific ethnic groups) where indicated.
- Hydration and Nutrition: Proactively manage fluid and electrolyte balance and ensure adequate nutritional support, often intravenously or via enteral feeding, due to severe oral pain.
🍽 Dietary Directions & Restrictions
- Soft/Liquid Diet: Due to severe and painful oral and pharyngeal erosions, patients typically require a soft, bland, or liquid diet.
- Nutritional Support: Many patients will require enteral (e.g., nasogastric tube) or parenteral nutrition if oral intake is severely compromised or impossible.
- Hydration Management: Aggressive intravenous fluid replacement is essential to compensate for significant fluid loss through denuded skin and impaired oral intake.
- Avoid Irritants: Restrict acidic, spicy, hot, or coarse foods and beverages that can exacerbate oral and esophageal lesions.
- Temperature Control: Prefer cool or lukewarm foods and liquids to minimize discomfort and irritation to damaged mucous membranes.
⚠️ Attendant Guidelines
- Immediate Transfer: Patients with suspected SJS/TEN require urgent transfer to a specialized burn unit or intensive care unit for expert management.
- Offending Drug Withdrawal: Prompt and complete discontinuation of all non-essential medications, especially the suspected causative agent, is the most critical intervention.
- Supportive Care Focus: Meticulous wound care, fluid and electrolyte balance, pain control, and aggressive infection prevention are paramount.
- Ocular Care: Regular ophthalmology consultation and intensive ocular lubrication are vital to prevent long-term vision impairment.
- Temperature Regulation: Monitor and manage body temperature closely, as extensive skin loss impairs thermoregulation.
- Psychological Support: Provide comprehensive emotional and psychological support for patients and their families coping with a severe, disfiguring, and life-threatening illness.
🩺 Physician's Perspective
- High Index of Suspicion: Maintain a high index of suspicion for SJS/TEN in any patient presenting with an acute, widespread rash and mucosal involvement, particularly following new medication exposure.
- Timely Diagnosis: Rapid diagnosis and immediate withdrawal of the offending drug are the most crucial factors influencing patient outcomes.
- Multidisciplinary Team: Effective management necessitates a collaborative approach involving dermatologists, intensivists, ophthalmologists, and burn specialists.
- Prognosis Awareness: Be aware of the significant mortality rates, especially in TEN, and the potential for severe long-term sequelae affecting multiple organ systems.
- Patient Education: Emphasize thorough patient and family education regarding the identified causative agent and the absolute necessity of avoiding future exposure to prevent recurrence.
🎓 Academic & Nursing Corner
- Comprehensive Assessment: Perform meticulous skin and mucosal assessments, documenting the extent of blistering and epidermal detachment (e.g., using the SCORTEN score).
- Aseptic Wound Care: Implement strict aseptic techniques for wound care, treating denuded areas similarly to severe burns to prevent secondary infections.
- Fluid Balance Monitoring: Accurately monitor intake and output, recognizing the significant fluid and electrolyte losses through extensive skin damage.
- Pain Management: Administer prescribed analgesics effectively, utilizing a multi-modal approach to manage the severe pain associated with SJS/TEN.
- Infection Surveillance: Closely monitor for signs of infection, including fever, changes in wound appearance, and elevated inflammatory markers.
- Psychosocial Support: Provide empathetic care, addressing the patient's and family's emotional distress and anxiety related to the severe nature of the illness.
🔬 Clinical Reference Index
- Pathophysiology: Characterized by widespread keratinocyte apoptosis, primarily mediated by cytotoxic T lymphocytes and granulysin, leading to epidermal detachment.
- SCORTEN Score: A validated prognostic tool used to estimate mortality risk in SJS/TEN based on seven clinical parameters (age, malignancy, heart rate, BSA detachment, serum urea, glucose, bicarbonate).
- Histopathology: Biopsy typically reveals full-thickness epidermal necrosis with a sparse lymphocytic infiltrate at the dermo-epidermal junction.
- Immunomodulatory Therapies: While supportive care is primary, various immunomodulatory agents (e.g., IVIG, cyclosporine, systemic corticosteroids) have been explored, with varying and often controversial evidence of efficacy.
- Long-Term Sequelae: Common complications include chronic dry eyes, corneal scarring, synechiae, skin dyspigmentation, scarring, nail dystrophy, and mucosal strictures.
- Pharmacogenomics: Specific HLA alleles (e.g., HLA-B*1502, HLA-B*5801) are strongly associated with an increased risk of SJS/TEN induced by certain drugs in genetically predisposed individuals.